ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 25

$1.03M Total Retail Price of All Prescriptions

Rank: 2 out of 25

722 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 722 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 13,467 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 749 736 1 2
AMLODIPINE BESYLATE 519 514 2 6
OMEPRAZOLE 459 427 3 1
METOPROLOL SUCCINATE 451 451 4 16
PRAVASTATIN SODIUM 426 394 5 26
SIMVASTATIN 395 390 6 4
LISINOPRIL 307 291 7 3
NAMENDA 262 262 8 21
LOSARTAN POTASSIUM 251 251 9 15
ATORVASTATIN CALCIUM 248 233 10 22
CRESTOR 246 238 11 34
HYDROCHLOROTHIAZIDE 240 216 12 14
SYNTHROID 239 234 13 43
HYDROCODONE-ACETAMINOPHEN 231 221 S3 14 7
FUROSEMIDE 226 223 15 5
DONEPEZIL HCL 225 225 16 19
CITALOPRAM HBR 188 182 17 10
METFORMIN HCL ER 173 168 18 63
ZOLPIDEM TARTRATE 173 169 18 38
ESCITALOPRAM OXALATE 167 166 20 32
SERTRALINE HCL 165 157 21 24
TORSEMIDE 158 158 22 87
RAMIPRIL 154 154 23 74
POTASSIUM CHLORIDE 152 151 24 12
METOPROLOL TARTRATE 141 137 25 9
ALENDRONATE SODIUM 138 138 26 20
PANTOPRAZOLE SODIUM 127 118 27 97
NEXIUM 122 122 28 79
ATENOLOL 116 114 29 11
TRAMADOL HCL 107 106 30 39
GABAPENTIN 104 103 31 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 104 31 72
DIOVAN 99 99 33 58
MELOXICAM 98 93 34 110
GLYBURIDE 97 91 R 35 112
METFORMIN HCL 97 83 35 13
LOSARTAN-HYDROCHLOROTHIAZIDE 97 97 35 60
FLUTICASONE PROPIONATE 94 88 38 50
TAMSULOSIN HCL 93 88 39 28
AMLODIPINE BESYLATE-BENAZEPRIL 92 92 40 113
TRAZODONE HCL 89 83 41 18
ZETIA 87 87 42 94
ACTONEL 81 81 43 120
VESICARE 79 79 44 122
LEVOFLOXACIN 78 76 45 90
AMITRIPTYLINE HCL 77 75 R 46 70
SPIRIVA 76 76 47 61
LEXAPRO 75 75 48 96
EXFORGE 75 75 48 126
CLONIDINE HCL 72 72 50 71
PLAVIX 71 71 51 78
WARFARIN SODIUM 70 70 52 8
CARVEDILOL 69 69 53 30
ALLOPURINOL 66 66 54 31
CYMBALTA 64 64 55 41
QUETIAPINE FUMARATE 63 63 56 48
DIOVAN HCT 60 52 57 139
DIGOXIN 58 58 58 33
LOVAZA 54 53 59 145
DILTIAZEM 24HR CD 54 54 59 106
CLOPIDOGREL 53 53 61 52
LIPITOR 51 48 62 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.